Concepedia

Nick Sanders

NS

Statistics

Publications

6

Citations

267

H-Index

6

Active since

2005

Affiliations

AstraZeneca (United Kingdom)(Current)

Loughborough University

National Institute of Oncology

Groote Schuur Hospital

Nick Sanders is an author at AstraZeneca (United Kingdom) specializing in pharmacology, education, and athletic performance.

Publications per year

2005–2016

6

Publications

6

Comparison of the COX‐inhibiting nitric oxide donator AZD3582 and rofecoxib in treating the signs and symptoms of Osteoarthritis of the knee

Thomas J. Schnitzer, Alan Kivitz, Robert Lipetz et al. · Arthritis Care & Research · 2005 · 60 citations

Medicine, Pharmacology, Pharmacotherapy +13

A Randomized, Double-Blind, Placebo-Controlled Phase II Study of Vandetanib Plus Docetaxel/Prednisolone in Patients with Hormone-Refractory Prostate Cancer

J Horti, Anders Widmark, Arnulf Stenzl et al. · Cancer Biotherapy and Radiopharmaceuticals · 2009 · 57 citations

Pharmacy, Pharmacology, Pharmacotherapy +16

Vandetanib with docetaxel as second-line treatment for advanced breast cancer: a double-blind, placebo-controlled, randomized Phase II study

Katalin Boér, István Láng, Antonio Llombart‐Cussac et al. · Investigational New Drugs · 2010 · 52 citations

Medicine, Oncology, Pharmacology +9

Player Load in Elite Netball: Match, Training, and Positional Comparisons

Chris M. Young, Paul B. Gastin, Nick Sanders et al. · International Journal of Sports Physiology and Performance · 2016 · 50 citations · Full text

Education, Kinesiology, Sports Medicine +9

Caffeine and performance in clay target shooting

Bianca L. Share, Nick Sanders, Justin G. Kemp · Journal of Sports Sciences · 2009 · 31 citations

Education, Kinesiology, Sports Medicine +13

1–5 of 6